Clinical Trial Update: A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma [Phase 2]

View source ↗

Summary

This entry notes a phase 2 clinical trial evaluating fianlimab, cemiplimab, and ipilimumab in advanced melanoma and indicates the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Advanced Melanoma | Phase 2 | Status: RECRUITING